Co-planar micro-impedance cytometry device
10816453 ยท 2020-10-27
Assignee
Inventors
Cpc classification
International classification
G01N15/12
PHYSICS
Abstract
An impedance cytometry device is described along with methods of accurately measuring particle size of particles contained in a fluid that is passed through the impedance cytometry device. The impedance cytometry device includes a substrate, and an electrode arrangement deposited on the substrate in a co-planar fashion. The electrode arrangement includes a drive electrode and a plurality of measurement electrodes located in a same plane as the drive electrode. The plurality of measurement electrodes includes at least two pairs of measurement sub-electrodes, each pair of measurement sub-electrodes including a first measurement sub-electrode positioned adjacent to the drive electrode, and a second measurement sub-electrode separated from the drive electrode by a respective first measurement sub-electrode. The impedance cytometry device may be incorporated into a substrate assembly of an electrowetting on dielectric (EWOD) device, such as in a substrate assembly containing electrowetting drive electrodes or a common reference electrode, or into a microfluidic blood counter device.
Claims
1. An impedance cytometry device comprising: a substrate; and an electrode arrangement deposited on the substrate in a co-planar fashion, the electrode arrangement comprising a drive electrode and a plurality of measurement electrodes located in a same plane as the drive electrode; wherein the plurality of measurement electrodes includes at least two pairs of measurement sub-electrodes, each pair of measurement sub-electrodes including a first measurement sub-electrode positioned adjacent to the drive electrode, and a second measurement sub-electrode separated from the drive electrode by a respective first measurement electrode; a sensing unit configured to measure current signals generated by the measurement sub-electrodes in response to the stimulus voltage, wherein the first measurement sub-electrodes are electrically connected to the sensing unit to generate a differential signal between the first measurement sub-electrodes of the at least two pairs of measurement sub-electrodes, and wherein the second measurement sub-electrodes are electronically connected to the sensing unit to generate a differential signal between the second measurement sub-electrodes of the at least two pairs of measurement sub-electrodes; and a control unit configured to receive the differential signals from the sensing unit and calculate impedance differences between the first measurement sub-electrodes of the at least two pairs of measurement sub-electrodes and between the second measurement sub-electrodes of the at least two pairs of measurement sub-electrodes, wherein the control unit processes the impedance differences to provide at least one of a count measurement and a diameter measurement of particles passing the measurement electrodes.
2. The impedance cytometry device of claim 1, wherein the sensing unit comprises a differential sensing circuit configured to measure differential current signals between first measurement sub-electrodes in different pairs of measurement electrodes, and to measure differential current signals between second measurement sub-electrodes in different pairs of measurement electrodes.
3. The impedance cytometry device of claim 1, wherein a width of the first measurement sub-electrodes along the substrate differs from a width of the second measurement sub-electrodes along the substrate.
4. The impedance cytometry device of claim 1, wherein within each pair of measurement sub-electrodes, a spacing between the first measurement sub-electrode and the drive electrode differs from a spacing between the first measurement sub-electrode and the second measurement sub-electrode.
5. The impedance cytometry device of claim 1, wherein different pairs of measurement sub-electrodes are located on opposite sides of a single drive electrode.
6. The impedance cytometry device of claim 1, wherein: the electrode arrangement comprises a first drive electrode and a second drive electrode; a first pair of measurement sub-electrodes includes a first measurement sub-electrode positioned adjacent to the first drive electrode, and a second measurement sub-electrode separated from the first drive electrode by the first measurement electrode; and a second pair of measurement electrodes includes another first measurement sub-electrode positioned adjacent to the second drive electrode, and another second measurement sub-electrode separated from the second drive electrode by the another first measurement electrode.
7. The impedance cytometry device of claim 1, wherein a width and/or separation of the first and second measurement sub-electrodes is between 1-50 m.
8. An electrowetting on dielectric (EWOD) device comprising: a substrate assembly that defines a microfluidic channel and includes electrowetting electrodes; and an impedance cytometry device of claim 1 incorporated into the substrate assembly.
9. The EWOD device of claim 8, wherein the substrate assembly comprises a substrate onto which is deposited the electrode arrangement of the impedance cytometry device and the electrowetting electrodes, an insulator layer deposited on the substrate, and a hydrophobic coating deposited on insulator layer to define the microfluidic channel.
10. The EWOD device of claim 9, wherein the electrode arrangement of the impedance cytometry device and the electrowetting electrodes are formed on a same plane on a surface of the substrate.
11. The EWOD device of claim 8, wherein the control circuit further is configured to dynamically switch operation of the drive electrode and the measurement electrodes between a cytometry function for performing the count and diameter measurement of particles passing the measurement electrodes, and an electrowetting function for performing electrowetting droplet manipulations.
12. An electrowetting on dielectric (EWOD) device comprising: a first substrate assembly and a second substrate assembly; wherein one of the first or second substrate assemblies includes electrowetting electrodes and the other of the first or second substrate assembly includes a common reference electrode, and the first substrate assembly and the second substrate assembly are spaced apart to define a microfluidic channel between the first and second substrate assemblies; and an impedance cytometry device of claim 1 incorporated into one of the first substrate assembly or the second substrate assembly.
13. The EWOD device of claim 12, wherein: the first substrate assembly comprises a first substrate onto which is deposited the electrode arrangement of the impedance cytometry device and the electrowetting electrodes, an insulator layer deposited on the first substrate, and a hydrophobic coating deposited on insulator layer to define the microfluidic channel; and the second substrate assembly comprises a second substrate onto which is deposited the common reference electrode, and a second hydrophobic coating deposited on common reference electrode to define the microfluidic channel.
14. The EWOD device of claim 12, wherein: the first substrate assembly comprises a first substrate onto which is deposited the electrowetting electrodes, an insulator layer deposited on the first substrate, and a hydrophobic coating deposited on insulator layer to define the microfluidic channel; and the second substrate assembly comprises a second substrate onto which is deposited the electrode arrangement of the impedance cytometry device and the common reference electrode, and a second hydrophobic coating deposited on common reference electrode to define the microfluidic channel.
Description
BRIEF DESCRIPTION OF DRAWINGS
(1) In the annexed drawings, like references indicate like parts or features:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
DESCRIPTION OF EMBODIMENTS
(17) Embodiments of the present invention will now be described with reference to the drawings, wherein like reference numerals are used to refer to like elements throughout. It will be understood that the figures are not necessarily to scale.
(18) In an exemplary embodiment of a first aspect of the present invention, a microfluidic impedance cytometry device is provided wherein electrodes for performing the measurement of particles in the microfluidic channel are positioned on a single planar surface and arranged so as to provide a measurement of the particle that is independent of the position of the particle in the microfluidic channel.
(19)
(20) The spacer 180 may be patterned so as to define the microfluidic channel along which a fluid 170 containing particles 160 to be measured may flow. In such case, a width of the channel may be chosen to be larger than, but of a similar magnitude to, the diameter of the particles 160 to be measured. In such case the channel width may, for example, typically be in the range of 1-100 m. As is well-known in the art, a height (z) of the gap may be chosen to be larger than, but of a similar magnitude to the diameter of, the particles 160 to be measured. For example, the diameter of particles 160 to be measured may typically be in the range of 0.5-50 m and the height of the gap may be in the range of 1-100 m. The microfluidic channel 150, therefore, may be configured along with control of the particle concentration in the fluid to ensure that generally a single particle is present at any particular (x, y) position in the channel gap and that the channel gap does not become blocked by particles.
(21) Electrodes 140 are formed on the first substrate 130 in the region of the gap 150. The electrodes may be in direct and therefore resistive electrical contact with the fluid present in the microfluidic channel. In such case the electrodes may be formed from a conductive material that is known to be inert, such as, for example, platinum, gold or the like. Alternatively, an insulator film may be formed over the electrodes such that there is no direct electrical contact between electrodes and the fluid. The electrodes are instead in indirect and therefore capacitive electrical contact with the fluid and deleterious effects, such as leakage resistance between electrodes, may be minimized. In such case the electrodes may be formed from any suitable conductive material and the insulator may be of a well-known type such as silicon dioxide, silicon nitride or aluminum oxide.
(22) Generally, with reference to subsequent figures, exemplary embodiments of an impedance cytometry device are described along with methods of accurately measuring particle size of particles contained in a fluid that is passed through the impedance cytometry device. In exemplary embodiments, the impedance cytometry device includes a substrate, and an electrode arrangement deposited on the substrate in a co-planar fashion. The electrode arrangement includes a drive electrode and a plurality of measurement electrodes located in a same plane as the drive electrode. The plurality of measurement electrodes includes at least two pairs of measurement sub-electrodes, each pair of measurement sub-electrodes including a first measurement sub-electrode positioned adjacent to the drive electrode, and a second measurement sub-electrode separated from the drive electrode by a respective first measurement electrode. The impedance cytometry device may be incorporated into a substrate assembly of an electrowetting on dielectric (EWOD) device, such as in a substrate assembly containing electrowetting drive electrodes, or in a substrate assembly containing a common reference electrode.
(23)
(24) First regions 260 of the gap or microfluidic channel 150 (denoted by a first shading pattern in the figure) may be defined as an area in a lower portion of the gap and between the drive electrode (D) 210 and the sets of measurement electrodes 220, 230, with some overlap of the sets of measurement electrodes within the channel. Similarly, second regions 265 of the gap or microfluidic channel 150 (denoted by a second shading pattern in the figure) may be defined as an area in an upper portion of the gap 150 and between the drive electrode 210 and the set of measurement electrodes 220, 230, also with some overlap of the sets of measurement electrodes within the channel, With the orientation of
(25) The first measurement sub-electrode (M1A, M2A) 240, 245 in each set of measurement electrodes is arranged such that the electric field lines associated with the electrical field coupling a respective first measurement sub-electrode and the driving electrode 210 are substantially present in only the first regions 260. Accordingly, the associated first impedances, Z.sub.1A and Z.sub.2A, may be used as a measure of disturbances in the electric field associated with a particle passing through the first regions 260. The second measurement sub-electrode (M1B, M2B) 250, 255 in each set of measurement electrodes is arranged such that the electric field lines associated with the electrical field coupling a respective second measurement sub-electrode and the driving electrode 210 are substantially present in only the second regions 265. Accordingly, the associated second impedances, Z.sub.1B and Z.sub.2B, may be used as a measure of disturbances in the electric field associated with a particle passing through the second regions 265.
(26) The effect described above is achieved when the width and separations of the measurement sub-electrodes in the x-dimension along the microfluidic channel 150 are chosen to be of a similar magnitude to both the gap 150 between the first substrate 130 and second substrate 120 and the diameter of the particles to be measured. For example, the width and separations of the measurement sub-electrodes may typically be in the range of 1-50 m. For the impedances associated with the first and second sets of measurement electrodes on either side of the drive electrode to be independently measured, the size of the drive electrode in the x-dimension may be chosen to be of a magnitude which is a multiple of both the gap 150 and the diameter of the particles to be measured.
(27) In operation, a fluid containing particles is forced to flow along the microfluidic channel 150 such that the particles pass by the electrodes 140. The concentration of particles in the fluid may be chosen such that only one particle passes by the electrodes at any one time. The resulting changes in the impedances, Z.sub.1A, Z.sub.1B, Z.sub.2A and Z.sub.2B, associated with the first and second sets of measurement electrodes may be measured by an impedance measurement unit 270 that is configured to measure impedance differences between measurement sub-electrodes of the plurality of measurement electrodes.
(28) The impedance measurement unit 270 may include a control unit 272 coupled to both a voltage stimulus unit 274 and a sensing unit 276. As is well-known in the art, the voltage stimulus unit 274 may be arranged to apply a driving voltage signal (Vs), for example a sinusoidal voltage stimulus of fixed amplitude and frequency, to the drive electrode 210. The sensing unit 276 may be arranged to measure the current signal generated on the measurement sub-electrodes in response to the voltage stimulus. The current signal of each measurement sub-electrode may be measured independently. Alternatively, a difference signal between pairs of measurement sub-electrodes may be measured using separate differential sensing circuits 278 within the sensing unit 276 that are configured to measure differential current signals between the different measurement electrodes. For example, as shown in
(29) In a conventional microfluidic impedance cytometry device with a co-planar electrode arrangement, the magnitude of the measured impedance signal is a function of both the particle diameter and the particle position in the gap in the z-direction that extends between the substrates. Accordingly, it is substantially difficult to accurately discriminate between particles of different diameters. Since fluid samples to be analyzed typically contain particles of many different sizes and types, conventional devices therefore have a significant disadvantage in that conventional devices cannot be used to reliably distinguish and count cells (e.g. blood cells, bacteria etc.) of a particular type. As further described below, an advantage of the present invention is that the device configured as disclosed may be used to reliably distinguish between and count particles of different sizes, or size ranges, corresponding to different types of particles to enable discriminating among different types of particles. For example, the present invention may discriminate between platelets, red blood cells and white blood cells (lymphocytes, neutrophils, monocytes, basophils and eosinophils) in a sample of human or animal blood.
(30) An aspect of the invention is a method of measuring particle size of particles in a fluid sample employing said impedance cytometry device. In exemplary embodiments, the measuring method includes the steps of passing the fluid sample containing particles through the impedance cytometry device; supplying a voltage stimulus to the drive electrode; measuring current signals generated on the measurement electrodes to determine impedance changes generated in response to a particle passing through electric fields generated by the measurement electrodes; and determining a particle size based on the impedance changes. Features of the measuring method may include measuring differential current signals between pairs of measurement sub-electrodes. Differential current signals may be used to determine differential impedances within first regions of the microfluidic channel in which electric fields are formed between the first measurement sub-electrodes and the drive electrode, and differential impedances within second regions of the microfluidic channel in which electric fields are formed between the second measurement sub-electrodes and the drive electrode, wherein the first regions are closer to the electrode arrangement than the second regions. A ratio between peaks magnitudes of the differential impedances in the first regions and the second regions may be determined and processed to provide an accurate determination of particle size.
(31)
(32) As shown by comparison of the relative peak magnitudes of the solid and dotted lines in
(33) Accordingly, the measured impedance signals may be processed to produce an accurate count of particles of a particular diameter, or particular range of diameters, passing by the electrodes that is independent of particle position in the gap in the z-direction. A processed impedance value can be calculated as a function of output voltages based on the measured differential impedances, including using the referenced ratio of the peak magnitudes of the two measured differential impedances. The processed impedance value can then be associated with particle size in a manner that is accurate and is independent of a particle's position within the microfluidic channel. For the example arrangement shown in
(34)
(35) where: Z is the processed output value V.sub.A(t) is the first output voltage signal from the sensor unit V.sub.B(t) is the second output voltage signal from the sensor unit n is a scaling factor which may be empirically derived.
(36) An example of the effect of applying such a processing method to the measured impedance signals is illustrated in
(37) It is noted that this uncorrected plot is equivalent to that generated from a conventional co-planar electrode arrangement. As shown by the plot, particles of different sizes and at different positions in the gap may generate similar uncorrected measurement results and therefore be indistinguishable from each other. Accordingly, conventional configurations are unable to distinguish among different particles based on particle size.
(38) On the other hand,
(39) Subsequent
(40)
(41) Alternatively or additionally, the same effect and advantage may be achieved by choosing the spacing between the first sub-electrodes, second sub-electrodes and drive electrode to be different.
(42)
(43) In another aspect of the invention, a microfluidic impedance cytometry device in accordance with any of the above embodiments is integrated or incorporated within an electrowetting-on-dielectric (EWOD) device. As is well known in the art, EWOD devices may be used to manipulate droplets of fluid by electronic means using electrowetting techniques. Integration of a microfluidic impedance cytometry device within an EWOD device allows the number of particles within a droplet to be counted. With an impedance cytometry device of sufficient accuracy, for example as described in this disclosure, the number of particles of a particular size and/or diameter may additionally be counted.
(44) In an exemplary embodiment of an EWOD device, electrodes for impedance cytometry are formed on the same substrate as the electrodes that are used to apply the electrowetting force for the actuation of droplets on the surface of the substrate.
(45)
(46)
(47) In an exemplary mode of operation of an EWOD device including an impedance cytometry device, a control circuit may be connected to the cytometry electrodes that enables the electrode function to be switched dynamically between a cytometry function in which a particle size is determined as to a particle in a fluid droplet as described above, and an electrowetting function in which a droplet manipulation is performed on the fluid droplet. Droplet manipulations, for example, may include forming droplets, moving droplets along the electrowetting array, splitting droplets, mixing droplets, determining or sensing droplet properties, and other droplet manipulations as may be known in the art of EWOD devices. The control circuit may be external to the device or may be formed on the substrate by, for example, thin film transistors.
(48)
(49) Typically, 1 l of whole human blood contains 5 million red blood cells (RBCs), 10,000 white blood cells (WBCs), and 500,000 platelets. To accurately count the number of WBCs, the RBCs must be removed, i.e., lysed within the mixing chamber 1185. To enable the RBCs to be counted accurately, a whole blood sample is diluted, for example in a 1:5,000 to 1:40,000 ratio. The whole blood sample may be diluted in a 1:10,000 to 1:20,000 ratio, or diluted in a 1:10,000 ratio. Platelets are counted preferably alongside the RBCs. It follows that there are two different sample preparation protocolsone for WBCs, and the other for RBCs and platelets combined.
(50) In one embodiment, the solution 1168 may be a lysis solution to lyse RBCs so that the WBCs can be differentiated and counted (up to a 5-part differential). The lysis solution is mixed with the sample input within the mixing chamber 1185, and the product of the mixing is then communicated through the fluidic channel 1190 with the integrated impedance cytometer 1100 for cell counting. The lysis reagent is any reagent mixture containing a chemical known to lyse RBCs, such as for example saponins, quaternary ammonium salts, or the like. Preferably, the lysis reagent used contains saponin. The lysis reagent may be 0.12% v/v formic acid and 0.05% w/v saponin.
(51) Optionally and/or additionally, a quench reagent may be further added after a pre-determined length of time for optimal lysis, wherein the quench reagent is any mixture known to halt or substantially reduce the rate of RBC lysis. The quench reagent may be 0.6% w/v sodium carbonate and 3% w/v sodium chloride. In exemplary embodiments, the blood:lysis:quench reagents are mixed in a ratio of 1:12:5.3. (See embodiments in U.S. Pat. No. 9,440,233 B2 Dothie et al, or U.S. Pat. No. 9,283,560 B2 Dothie).
(52) Alternatively, the solution 1168 could be a diluent solution so that RBCs and platelets can be sufficiently diluted to enable accurate quantification of RBCs and platelets. The diluent reagent is one compatible with RBCs and platelets. Compatible implies that the reagent in question does not cause serious degradation to the sample, nor promotes clotting of either the RBCs or the platelets. Dilutent reagents may include, but are not limited to, PBS, running buffer (comprising PBS, 2 mM EDTA, 0.5% BSA), and the like.
(53) The embodiment may further include performing a haemoglobin measurement in a haemoglobin measurement chamber, such is in the chamber 1165 holding the solution 1168. For haemoglobin to be measured accurately, the RBCs must be lysed. It follows that the most preferable position for the haemoglobin measurement is after the RBCs have been lysed in the WBC counting prototcol. It is further preferable to convert the haemoglobin into a stable oxidized form (methemoglobin) by adding chemical haemoglobin reagent mixtures. Suitable reagents include, but are not limited to, Drabkins's reagent (which contains sodium bicarbonate, potassium ferricyanide and potassium cyanide and converts haemoglobin into cyanmethemoglobin), ferrocyanide, or the like. Such haemoglobin reagents could be pre-dried in the haemoglobin measurement chamber. In practice, haemoglobin is converted to cyanmethemoglobin (e.g. by reacting the blood with a Drabkin's reagent) and measured spectrophotometrically (the reacted Drabkin's reagent and haemoglobin form a stable, coloured end-product). A simple LED/photodiode combination can be employed for the quantitative, colourimetric determination of blood haemoglobin using absorbance in accordance with Beer's law, as is known in the art.
(54) After cell counting, and the haemoglobin measurement, the processed blood samples are collected in a waste chamber.
(55) The two different sample processing protocols for WBCs and RBCs/platelets may be carried out on separate cartridges, and the cells of interest counted on separate impedance sensors. An alternative embodiment would carry out the processing protocols for WBCs and RBCs/platelets in parallel, and then count e.g. the WBCs then the RBCs/platelets on a single impedance chip in series. In a further alternative embodiment, the two different sample processing protocols could be carried out in series and the e.g. WBCs followed by the RBCs/platelets counted on a single impedance sensor.
(56) Alternatively and/or additionally, co-planar impedance cytometers as described in this patent can be integrated into microfluidic blood cell counters of the types described in the following patents; U.S. Pat. No. 7,771,658 B2 Larsen et al, U.S. Pat. No. 9,440,233 B2 Dothie et al, or U.S. Pat. No. 9,283,560 B2 Dothie.
(57)
(58) EWOD technology is well suited to merging, mixing, splitting and moving droplets, offering several ease-of-workflow benefits compared to mechanical microfluidic cartridges.
(59)
(60) The two different sample processing protocols for WBCs and RBCs/platelets may be carried out simultaneously and the cells of interest counted on separate impedance sensors. An alternative embodiment would carry out the processing protocols for WBCs and RBCs/platelets in parallel, and then count e.g. the WBCs then the RBCs/platelets on a single impedance chip in series. In a further alternative embodiment, the two different sample processing protocols could be carried out in series and the e.g. WBCs followed by the RBCs/platelets counted on a single impedance sensor.
(61) An aspect of the invention, therefore, is an impedance cytometry device including a substrate and an electrode arrangement deposited on the substrate in a co-planar fashion, the electrode arrangement comprising a drive electrode and a plurality of measurement electrodes located in a same plane as the drive electrode. The plurality of measurement electrodes includes at least two pairs of measurement sub-electrodes, each pair of measurement sub-electrodes including a first measurement sub-electrode positioned adjacent to the drive electrode, and a second measurement sub-electrode separated from the drive electrode by a respective first measurement electrode. The impedance cytometry device may include one or more of the following features, either individually or in combination.
(62) In an exemplary embodiment of the impedance cytometry device, the device further includes an impedance measurement unit configured to measure impedance differences between measurement sub-electrodes of the plurality of measurement electrodes.
(63) In an exemplary embodiment of the impedance cytometry device, the impedance measurement unit comprises: a voltage stimulus unit configured to supply a stimulus voltage to the drive electrode; a sensing unit configured to measure current signals generated by the measurement sub-electrodes in response to the stimulus voltage; and a control unit configured to receive output signals from the sensing unit and calculate the impedance differences, wherein the control unit processes the impedance differences to provide a measurement of particles passing the measurement electrodes.
(64) In an exemplary embodiment of the impedance cytometry device, the sensing unit comprises a differential sensing circuit configured to measure differential current signals between first measurement sub-electrodes in different pairs of measurement electrodes, and to measure differential current signals between second measurement sub-electrodes in different pairs of measurement electrodes.
(65) In an exemplary embodiment of the impedance cytometry device, a width of the first measurement sub-electrodes along the substrate differs from a width of the second measurement sub-electrodes along the substrate.
(66) In an exemplary embodiment of the impedance cytometry device, within each pair of measurement sub-electrodes, a spacing between the first measurement sub-electrode and the drive electrode differs from a spacing between the first measurement sub-electrode and the second measurement sub-electrode.
(67) In an exemplary embodiment of the impedance cytometry device, different pairs of measurement sub-electrodes are located on opposite sides of a single drive electrode.
(68) In an exemplary embodiment of the impedance cytometry device, the electrode arrangement comprises a first drive electrode and a second drive electrode; a first pair of measurement sub-electrodes includes a first measurement sub-electrode positioned adjacent to the first drive electrode, and a second measurement sub-electrode separated from the first drive electrode by the first measurement electrode; and a second pair of measurement electrodes includes another first measurement sub-electrode positioned adjacent to the second drive electrode, and another second measurement sub-electrode separated from the second drive electrode by the another first measurement electrode.
(69) In an exemplary embodiment of the impedance cytometry device, a width and/or separation of the first and second measurement sub-electrodes is between 1-50 m.
(70) Another aspect of the invention is an electrowetting on dielectric (EWOD) device including a substrate assembly that defines a microfluidic channel and includes electrowetting electrodes; and an impedance cytometry device in accordance with any of the embodiments. The EWOD device may include one or more of the following features, either individually or in combination.
(71) In an exemplary embodiment of the EWOD device, the substrate assembly comprises a substrate onto which is deposited the electrode arrangement of the impedance cytometry device and the electrowetting electrodes, an insulator layer deposited on the substrate, and a hydrophobic coating deposited on insulator layer to define the microfluidic channel.
(72) In an exemplary embodiment of the EWOD device, the electrode arrangement of the impedance cytometry device and the electrowetting electrodes are formed on a same plane on a surface of the substrate.
(73) In an exemplary embodiment of the EWOD device, the device includes a first substrate assembly and a second substrate assembly; wherein one of the first or second substrate assemblies includes electrowetting electrodes and the other of the first or second substrate assembly includes a common reference electrode, and the first substrate assembly and the second substrate assembly are spaced apart to define a microfluidic channel between the first and second substrate assemblies; and an impedance cytometry device of any of claims 1-9 incorporated into one of the first substrate assembly or the second substrate assembly.
(74) In an exemplary embodiment of the EWOD device, the first substrate assembly comprises a first substrate onto which is deposited the electrode arrangement of the impedance cytometry device and the electrowetting electrodes, an insulator layer deposited on the first substrate, and a hydrophobic coating deposited on insulator layer to define the microfluidic channel; and the second substrate assembly comprises a second substrate onto which is deposited the common reference electrode, and a second hydrophobic coating deposited on common reference electrode to define the microfluidic channel.
(75) In an exemplary embodiment of the EWOD device, the first substrate assembly comprises a first substrate onto which is deposited the electrowetting electrodes, an insulator layer deposited on the first substrate, and a hydrophobic coating deposited on insulator layer to define the microfluidic channel; and the second substrate assembly comprises a second substrate onto which is deposited the electrode arrangement of the impedance cytometry device and the common reference electrode, and a second hydrophobic coating deposited on common reference electrode to define the microfluidic channel.
(76) Another aspect of the invention is a microfluidic cell counting device having the enhanced impedance cytometry device. In exemplary embodiments, the microfluidic cell counting device includes a chamber for receiving a reagent solution; a rotating valve for receiving a sample input, the rotating valve including an internal channel that meters a predetermined amount of the sample input; a mixing chamber in fluid communication with the rotating valve, wherein the sample input and reagent solution are communicated to the mixing chamber by operation of the rotating valve and mixed within the mixing chamber; and a fluidic channel in fluid communication with the mixing chamber, the fluidic channel including the impedance cytometry device of any of the embodiments incorporated into the fluidic channel, wherein cells in the sample input are counted based on impedance measurements taken at the impedance cytometry device.
(77) Another aspect of the invention is a method of measuring particle size in a fluid sample using the enhanced impedance cytometry device. In exemplary embodiments, the measuring method includes the steps of: passing the fluid sample containing particles through an impedance cytometry device that defines a microfluidic channel, supplying a voltage stimulus to the drive electrode; measuring current signals generated on the measurement sub-electrodes to determine impedance changes generated in response to a particle passing through electric fields generated by the measurement electrodes; and determining a particle size based on the impedance changes. The measuring method may include one or more of the following features, either individually or in combination.
(78) In an exemplary embodiment of the measuring method, measuring current signals generated on the measurement sub-electrodes comprises measuring differential current signals between pairs of measurement sub-electrodes.
(79) In an exemplary embodiment of the measuring method, measuring differential current signals comprises measuring differential current signals between the first measurement sub-electrodes in first and second pairs of measurement electrodes, and between the second measurement sub-electrodes in the first and second pairs of measurement electrodes.
(80) In an exemplary embodiment of the measuring method, determining the impedance changes comprises: determining impedance differentials within first regions of the microfluidic channel in which electric fields are formed between the first measurement sub-electrodes and the drive electrode; and determining impedance differentials within second regions of the microfluidic channel in which electric fields are formed between the second measurement sub-electrodes and the drive electrode; wherein the first regions are closer to the electrode arrangement than the second regions.
(81) In an exemplary embodiment of the measuring method, the method further includes determining a ratio between peak magnitudes of the differential impedances in the first regions and the second regions; calculating a processed impedance value as a function of output voltages based on the measured differential impedances, including using the ratio of the peak magnitudes of the differential impedances; and determining particle size based on the processed impedance value.
(82) In an exemplary embodiment of the measuring method, the method further includes sizing the microfluidic channel and controlling a concentration of particles in the fluid such that only one particle passes through the impedance cytometry device at a time.
(83) In an exemplary embodiment of the measuring method, the method further includes incorporating the impedance cytometry device into an electrowetting on dielectric (EWOD) device, wherein the impedance cytometry device is incorporated into one of the first substrate assembly or the second substrate assembly.
(84) In an exemplary embodiment of the measuring method, the method further includes switching dynamically between a cytometry function in which a particle size is determined as to a particle in a fluid droplet, and an electrowetting function in which a droplet manipulation is performed on the fluid droplet.
(85) In an exemplary embodiment of the measuring method, the method further includes incorporating the impedance cytometry device into a microfluidic cell counting device; inputting the reagent solution into the chamber; inputting the sample input into the rotating valve, thereby metering the sample input; operating the rotating valve to communicate the sample input and a portion of the reagent solution into the mixing chamber; wherein the sample input and the portion of the reagent solution are mixed within the mixing chamber; and communicating the mixed sample input and reagent solution through the fluidic channel to the impedance cytometry device, wherein cells in the sample input are counted based on impedance measurements taken at the impedance cytometry.
(86) In an exemplary embodiment of the measuring method, the sample input is a blood sample, and the method further comprises counting one or more red blood cells, white blood cells, and platelets in the sample input.
(87) Although the invention has been shown and described with respect to a certain embodiment or embodiments, equivalent alterations and modifications may occur to others skilled in the art upon the reading and understanding of this specification and the annexed drawings. In particular regard to the various functions performed by the above described elements (components, assemblies, devices, compositions, etc.), the terms (including a reference to a means) used to describe such elements are intended to correspond, unless otherwise indicated, to any element which performs the specified function of the described element (i.e., that is functionally equivalent), even though not structurally equivalent to the disclosed structure which performs the function in the herein exemplary embodiment or embodiments of the invention. In addition, while a particular feature of the invention may have been described above with respect to only one or more of several embodiments, such feature may be combined with one or more other features of the other embodiments, as may be desired and advantageous for any given or particular application.
INDUSTRIAL APPLICABILITY
(88) The present invention finds application as a method of counting particles within a microfluidic device. The present invention additionally finds application as a method of counting particles of a particular size, or diameter, within a microfluidic device. Such devices may be used, for example, to count cells such as bacterial, animal, plant or human cells within a sample of a biological fluid. Applications may include, for example, counting blood cells in human blood samples and providing a full blood cell count.
REFERENCE SIGNS LIST
(89) 100microfluidic device 120second substrate 130first substrate 140electrodes 150microfluidic channel or gap 160particles 170fluid 180spacer 210drive electrode 220first set of measurement electrodes 230second set of measurement electrodes 240, 245first measurement sub-electrode 250, 255second measurement sub-electrode 260first region 265second region 270impedance measurement unit 272control unit 274voltage stimulus unit 276differential sensing unit 278sensing unit 600electrode arrangement 610drive electrode 620first set of measurement electrodes 630second set of measurement electrodes 635substrate 640, 645first measurement sub-electrodes 650, 655second measurement sub-electrodes 660first spacing 670second spacing 700electrode arrangement 710first drive electrode 715second drive electrode 720first set of measurement electrodes 730second set of measurement electrodes 735substrate 740, 745first measurement sub-electrodes 750, 755second measurement sub-electrodes 800EWOD device 810substrate 820electrowetting electrodes 840cytometry electrodes 850insulating layer 860hydrophobic coating layer 870fluid droplet 900EWOD device 910first substrate 915second substrate 920electrowetting electrodes 925reference electrode 940cytometry electrodes 950insulating layer 960first hydrophobic coating layer 965second hydrophobic coating layer 970fluid droplet 1000EWOD device 1010first substrate 1015second substrate 1020electrowetting electrodes 1025reference electrodes 1040cytometry electrodes 1050insulating layer 1060first hydrophobic coating layer 1065second hydrophobic coating layer 1070fluid droplet 1100impedance cytometer 1160microfluidic device 1165first chamber 1168solution 1170rotating valve 1175aperture 1180small volume of blood 1185mixing chamber 1190fluidic channel 1195waste chamber 1200EWOD device 1210bottom plate 1215top plate 1240impedance cytometer 1275droplet of whole blood 1280solution droplet 1285mixed droplet 1290daughter droplet